…in the process of the technology transfer of the prototype and related manufacturing procedures for the saliva-based rapid SARS-CoV-2 antigen test from Cytiva to BBI. Avacta aims to begin clinical…
…could be the answer. Dr Don Mahad, Lead Author and Senior Clinical Lecturer at the University of Edinburgh, said: “Disability in MS is caused by a loss of nerve fibres…
…discovered the role of carotid bodies in hypertension and kidney diseases. She also has gained a wealth of expertise in developing fit-for-purpose animal models used in clinical translation. In her…
…of the agreement, research teams from both organisations will collaborate to develop follow-on technologies to support the purification of viruses and viral vectors for research and clinical use. One of…
…and development, and phase I clinical trial testing of a DNA vaccine against COVID-19, as part of the Opencorona consortium to support global efforts tackling the pandemic. Partners in the…
…overcome the key challenges of drug design and select lead candidates with the best chances of clinical success. The platform evaluates specificity, functionality, safety and manufacturability of antibodies to reduce…
…service partner spanning throughout the product lifecycle – from comparator sourcing for clinical trials, through early access programs to licensing and commercialization of products, today announces that Stefan Fraenkel, Executive…
…compound, ETX001, to enhance the activity of TMEM16A in human bronchial epithelial cells from CF patients, increasing epithelial fluid secretion and mucus clearance providing the first pre-clinical proof of principle…
…4.0 software, which provides greater flexibility and customisation for this growing industry. Thermo Fisher Scientific said its partnership with provider of sample preparation technologies for protein-based clinical research, Evosep, recently…
…and ERAP2 modulators.” Grey Wolf is expanding efforts around ERAP2 for two reasons. First, clinical data continues to demonstrate that tumors which are more visible to the immune system show…
…support the evaluation of mRNA-1273 in clinical efficacy trials. They also explain how their prior research on a candidate MERS-CoV vaccine paved the way for a rapid response to the…
…need for new in vitro tools that better predict clinical outcomes, it is a privilege to be working for a company whose potential to make a difference is so great.”…
This a new clinical development partnership to progress a therapeutic DNA vaccine, TGL-100, into an early phase clinical trial targeting head and neck squamous cell carcinoma (HNSCC) HNSCC is the…
…to market. Significant advances have been made in recent years in the use of cell and gene therapies in disease areas with unmet clinical needs. However, reliable methods are still…
…safety, lower attrition rates in clinical studies, and a faster time to market to help patients with severe diseases worldwide through novel therapies,” said Dr. Friedrich von Bohlen, Molecular Health…
…sizes, from non-profit organizations and early stage startups to clinical stage biotechnology and large pharmaceutical companies, in their journey to develop much-needed novel therapeutic products using our expression platform.” Dr….
